Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
- Status
- COMPLETED
- Phase
- N/A
Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread
- Status
- COMPLETED
- Phase
- N/A
Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico
- Status
- WITHDRAWN
- Phase
- N/A
GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread
- Status
- COMPLETED
- Phase
- N/A
A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
Real-World Evidence and Treatment Patterns: Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines
- Status
- COMPLETED
- Phase
- PHASE2
Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology
- Status
- TERMINATED
- Phase
- N/A
Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas
- Status
- WITHDRAWN
- Phase
- PHASE2
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
- Status
- COMPLETED
- Phase
- PHASE3
A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1